Please login to the form below

F2G

This page shows the latest F2G news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s John Rex joins UK biotech F2G

John Rex has moved from AstraZeneca to F2G to become the Manchester, UK-based drug discovery firm's chief medical officer. ... new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials.
F2G appoints chief financial officer

Ralf Schmid brings experience from Nabriva Therapeutics. Manchester-based F2G Ltd has appointed Ralf Schmid as its new chief financial officer. ... Ian Nicholson, chief executive of F2G, said: “Following our successful $60m financing, I am delighted to

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Add my company

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....